文献速递药物不良反应与药物警戒

COVID-19疫苗接种后急性阑尾炎病例报告及形态学分析

Acute appendicitis in a patient immunised with COVID-19 vaccine: A case report with morphological analysis.
PubMed 文献 · Br J Clin Pharmacol · 2022-06-07

本文报告一例58岁女性在接种首剂Pfizer-BioNTech COVID-19疫苗约48小时后出现阑尾炎症状的病例,影像学提示急性阑尾炎,且病理显示Th-1驱动的肉芽肿性炎症。结合临床试验和观察性研究提示阑尾炎可能与COVID-19疫苗相关,建议监测mRNA疫苗的胃肠道不良事件。

要点

  • 接种mRNA COVID-19疫苗后48小时内出现阑尾炎症状需警惕。
  • 病理可见Th-1驱动肉芽肿性炎症,属少见非特异性慢性阑尾炎。
  • 建议监测mRNA疫苗相关胃肠道不良事件,及时处理症状。

核心结论

  • 阑尾炎被视为COVID-19疫苗的特殊关注不良事件,本病例提示接种后可能出现急性阑尾炎。

研究设计与样本

  • 单例病例报告,描述一例58岁女性接种首剂Pfizer-BioNTech疫苗后约48小时出现阑尾炎症状,并进行了形态学分析。

主要发现

  • 腹部超声显示右髂窝积液和盲肠壁增厚,增强CT显示阑尾扩张伴壁增厚,提示急性阑尾炎。
  • 患者上呼吸道COVID-19逆转录聚合酶链反应检测阴性。
  • 病理报告Th-1驱动的肉芽肿性炎症,为少见的非特异性慢性阑尾炎,尤其在延迟或间期阑尾切除术背景下。

临床怎么用

  • 接种mRNA COVID-19疫苗后出现胃肠道症状时应警惕阑尾炎等不良事件,及时评估和处理以预防并发症。

局限性

  • 单例病例报告,无法确立因果关系;需更大规模研究验证疫苗与阑尾炎的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although the benefit/risk profile for mRNA COVID-19 vaccines is recognised as extremely favourable, appendicitis is currently considered an adverse event (AE) of special interest. We describe the case of a 58-year-old female who presented with signs and symptoms of appendicitis approximately 48 hours after her first injection of the Pfizer-BioNTech vaccine. Abdominal ultrasound revealed fluid collection in the right iliac fossa and cecal wall thickening. Following the surgical visit, CT scan with contrast showed a distended appendix with thickened walls, suggestive of acute appendicitis. The patient tested negative to upper respiratory COVID-19 reverse transcription-polymerase chain reaction. Clinical trials and observational studies suggest a possible association between appendicitis and COVID-19 vaccines. Th-1 driven granulomatous inflammation reported in our case represents an infrequent nonspecific chronic inflammation of the appendix, especially in the setting of delayed or interval appendectomy. In view of the current paediatric vaccination campaign, we recommend monitoring the safety profile and potential gastrointestinal AEs associated with mRNA COVID-19 vaccines to swiftly manage subjects with gastrointestinal symptoms and prevent potential complications.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Marconi E, Crescioli G, Bonaiuti R, et al. Acute appendicitis in a patient immunised with COVID-19 vaccine: A case report with morphological analysis. Br J Clin Pharmacol. 2022. PMID: 35633085. doi:10.1111/bcp.15421

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。